The most common renal cancer is renal cell carcinoma (RCC), which arises from the renal
parenchyma. The global incidence of RCC has increased over the past two decades by 2 …

Background Partial nephrectomy and radical nephrectomy are the relevant surgical therapy
options for localised renal cell carcinoma. However, debate regarding the effects of these …

Purpose To provide recommendations for the management options for patients with small
renal masses (SRMs). Methods By using a literature search and prospectively defined study …

BACKGROUND: Radiofrequency ablation (RFA) of renal cell carcinoma (RCC) is used to
obtain local control of small renal masses. However, available long-term oncologic …

Historically, kidney cancer was approached in a siloed single-speciality way, with urological
surgeons managing the localised stages of the disease and medical oncologists caring for …

Purpose To evaluate the long-term efficacy of image-guided cryoablation of sporadic clinical
T1 (cT1) biopsy-proven renal cell carcinoma (RCC) and the technical success and safety of …

With imaging, most incidental renal masses can be diagnosed promptly and with confidence
as being either benign or malignant. For those that cannot, management recommendations …

Aim To update the recommendations for the management of kidney cancers. Methods A
systematic review of the literature was conducted from 2015 to 2022. The most relevant …

Background: The standard treatment of T1 renal cell carcinoma (RCC) is (partial)
nephrectomy. For patients where surgery is not the treatment of choice, for example in the …

Purpose The COVID-19 pandemic has led to the cancellation or deferment of many elective
cancer surgeries. We performed a systematic review on the oncological effects of delayed …